Brevan Howard Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,976	Closed	-$422K	–	1175
2024 Q4	$422K	Buy	+8,976	New	+$422K	﹤0.01%	639
2024 Q2	–	Sell	-14,990	Closed	-$1.05M	–	1071
2024 Q1	$1.05M	Buy	14,990 +6,924	+86%	+$485K	0.01%	204
2023 Q4	$673K	Buy	+8,066	New	+$673K	0.01%	324